1. Home
  2. SLVM vs ANIP Comparison

SLVM vs ANIP Comparison

Compare SLVM & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sylvamo Corporation

SLVM

Sylvamo Corporation

HOLD

Current Price

$34.79

Market Cap

1.7B

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$71.55

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLVM
ANIP
Founded
1898
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
SLVM
ANIP
Price
$34.79
$71.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$54.00
$110.00
AVG Volume (30 Days)
198.2K
308.5K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
4.15%
N/A
EPS Growth
N/A
419.23
EPS
N/A
2.32
Revenue
$3,351,000,000.00
$206,547,000.00
Revenue This Year
$0.93
$21.01
Revenue Next Year
$1.54
$17.59
P/E Ratio
N/A
$30.25
Revenue Growth
N/A
2.47
52 Week Low
$34.25
$69.58
52 Week High
$56.80
$99.39

Technical Indicators

Market Signals
Indicator
SLVM
ANIP
Relative Strength Index (RSI) 41.07 36.54
Support Level $34.25 $70.15
Resistance Level $40.13 $83.20
Average True Range (ATR) 1.16 1.76
MACD -0.03 -0.13
Stochastic Oscillator 31.45 12.62

Price Performance

Historical Comparison
SLVM
ANIP

About SLVM Sylvamo Corporation

Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills. It produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers, and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: